Clinical Trial Update: Pharmacodynamics, Safety, Tolerability, and Pharmacokinetics of Two Orally Inhaled Indacaterol Salts in Adult Subjects With Asthma. [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating pharmacodynamics, safety, tolerability, and pharmacokinetics of two orally inhaled indacaterol salts in adults with asthma has comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Indacaterol salts (orally inhaled) (indacaterol)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Asthma | Phase 2 | Status: COMPLETED | Results posted: 2019-03-29